drug manufacturing

GlaxoSmithKline Invests $360 Mln in U.K. Despite Brexit Vote

By Ben Hirschler LONDON, July 27 – GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signalling its confidence in the country despite last month’s vote to leave the European Union. Britain’s biggest drugmaker, which had argued against Brexit before the referendum, believes the UK remains an

[ Read More ]